144 related articles for article (PubMed ID: 32014801)
1. Generation of an induced pluripotent stem cell line (SDQLCHi009-A) from a patient with 47,XXY and ornithine transcarbamylase deficiency carrying a hemizygote mutation in OTC.
Yang X; Yan B; Zhang H; Ma Y; Zhou Q; Li Y; Guan J; Wang D; Liu Y; Gai Z
Stem Cell Res; 2020 Mar; 43():101704. PubMed ID: 32014801
[TBL] [Abstract][Full Text] [Related]
2. Generation of a human induced pluripotent stem cell line (SDQLCHi036-A) from a patient with ornithine transcarbamylase deficiency carrying a deletion involving 3-9 exons of OTC gene.
Guan J; Yan B; Zhang H; Liu C; Li Y; Yang X; Li Z; Gai Z; Liu Y
Stem Cell Res; 2021 Apr; 52():102220. PubMed ID: 33550136
[TBL] [Abstract][Full Text] [Related]
3. A novel mutation in ornithine transcarbamylase gene causing mild intermittent hyperammonemia.
Mohamed S; Hamad MH; Kondkar AA; Abu-Amero KK
Saudi Med J; 2015 Oct; 36(10):1229-32. PubMed ID: 26446336
[TBL] [Abstract][Full Text] [Related]
4. An OTC deficiency 'phenocopy' in association with Klinefelter syndrome.
Swarts L; Leisegang F; Owen EP; Henderson HE
J Inherit Metab Dis; 2007 Feb; 30(1):101. PubMed ID: 17186414
[TBL] [Abstract][Full Text] [Related]
5. Establishment of a non-integrate iPS cell line (SDQLCHi023-A) from a patient with Xq25 microduplication syndrome carrying a 1.3 Mb hemizygote duplication at chrXq25.
Yang X; Duan C; Zhang H; Li Y; Guan J; Wang D; Lv Y; Gai Z; Liu Y
Stem Cell Res; 2021 Mar; 51():102147. PubMed ID: 33493992
[TBL] [Abstract][Full Text] [Related]
6. Ornithine transcarbamylase (OTC) deficiency based on a hemizygous p.R277W mutation causing life-threatening hyperammonemic crisis during treatment for Hodgkin's lymphoma.
Ritter E; Husain RA; Hinderhofer K; Prell T; Fricke HJ; Scholl S; Hochhaus A; La Rosée P
Ann Hematol; 2011 Jul; 90(7):857-9. PubMed ID: 21061009
[No Abstract] [Full Text] [Related]
7. Gene Mutation Analysis and Prenatal Diagnosis of the Ornithine Transcarbamylase (OTC) Gene in Two Families with Ornithine Transcarbamylase Deficiency.
Li S; Cai Y; Shi C; Liu M; Liu B; Lin L; Xiao X; Hao H
Med Sci Monit; 2018 Oct; 24():7431-7437. PubMed ID: 30333473
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of ornithine transcarbamylase gene mutations in three boys affected with late-onset ornithine transcarbamylase deficiency].
Chen Z; Wen P; Wang G; Liu X; Chen L; Chen S; Wan L; Cui D; Shang Y; Li C
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2014 Oct; 31(5):565-9. PubMed ID: 25297582
[TBL] [Abstract][Full Text] [Related]
9. Low citrulline may not be diagnostic of ornithine transcarbamylase deficiency: a case report.
Chiong MA; Carpenter K; Christodoulou J
J Inherit Metab Dis; 2007 Jun; 30(3):405. PubMed ID: 17407001
[TBL] [Abstract][Full Text] [Related]
10. [Molecular diagnosis of OTC gene mutation in a Chinese family with ornithine transcarbamylase deficiency].
Meng LL; Jiang T; Qin L; Ma DY; Chen YL; Han SP; Yu ZB; Guo XR; Hu P; Xu ZF
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Apr; 30(2):195-8. PubMed ID: 23568734
[TBL] [Abstract][Full Text] [Related]
11. [Molecular characterization of a new mutation E122G of human ornithine transcarbamylase gene].
Gao H; Li W; Yan ZH; Jiang MH; Rui DR; He YS
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Feb; 20(1):19-22. PubMed ID: 12579493
[TBL] [Abstract][Full Text] [Related]
12. Genotype-Phenotype Correlations in Ornithine Transcarbamylase Deficiency: A Mutation Update.
Caldovic L; Abdikarim I; Narain S; Tuchman M; Morizono H
J Genet Genomics; 2015 May; 42(5):181-94. PubMed ID: 26059767
[TBL] [Abstract][Full Text] [Related]
13. Establishment of an induced pluripotent stem cell line (NCKDi003-A) from a patient with X-linked Dent disease (X-Dent) carrying the hemizygote mutation p. T277P (c. 829A > C) in the CLCN5 gene.
Hu L; Wang G; Wu H; Fu H; Wang Y; Yu F; Liu Z; Mao J
Stem Cell Res; 2021 Oct; 56():102538. PubMed ID: 34547705
[TBL] [Abstract][Full Text] [Related]
14. Lymphocyte mRNA analysis of the ornithine transcarbamylase gene in Italian OTCD male patients and manifesting carriers: identification of novel mutations.
Giorgi M; Morrone A; Donati MA; Ciani F; Bardelli T; Biasucci G; Zammarchi E
Hum Mutat; 2000 Apr; 15(4):380-1. PubMed ID: 10737985
[TBL] [Abstract][Full Text] [Related]
15. A novel splice site mutation in
Olga S; Natalia S; Igor B; Alena C; Ekaterina Z; Oksana R; Zhanna M; Nadezhda S; Aleksander P
J Genet; 2020; 99():. PubMed ID: 32482918
[TBL] [Abstract][Full Text] [Related]
16. Mutation analysis of the ornithine transcarbamylase (OTC) gene in five Japanese OTC deficiency patients revealed two known and three novel mutations including a deep intronic mutation.
Ogino W; Takeshima Y; Nishiyama A; Okizuka Y; Yagi M; Tsuneishi S; Saiki K; Kugo M; Matsuo M
Kobe J Med Sci; 2007; 53(5):229-40. PubMed ID: 18204299
[TBL] [Abstract][Full Text] [Related]
17. Ornithine transcarbamylase deficiency: a novel splice site mutation in a family with meiotic recombination and a new useful SNP for diagnosis.
Azevedo L; Vilarinho L; Teles EL; Amorim A
Mol Genet Metab; 2002 May; 76(1):68-70. PubMed ID: 12175783
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of clinical features, biochemical analysis and gene mutations in one Chinese pedigree with neonatal-onset ornithine transcarbamylase deficiency].
Sun WH; Yang Y; Zhang YP; Li XT; Zhang M; Cao Y; Wang Y
Zhonghua Er Ke Za Zhi; 2011 May; 49(5):356-60. PubMed ID: 21624287
[TBL] [Abstract][Full Text] [Related]
19. Disease-causing mutations in the promoter and enhancer of the ornithine transcarbamylase gene.
Jang YJ; LaBella AL; Feeney TP; Braverman N; Tuchman M; Morizono H; Ah Mew N; Caldovic L
Hum Mutat; 2018 Apr; 39(4):527-536. PubMed ID: 29282796
[TBL] [Abstract][Full Text] [Related]
20. Activity of the liver enzyme ornithine carbamoyltransferase (OTC) in blood: LC-MS/MS assay for non-invasive diagnosis of ornithine carbamoyltransferase deficiency.
Krijt J; Sokolová J; Ješina P; Dvořáková L; Řeboun M; Brennerová K; Mistrík M; Zeman J; Honzík T; Kožich V
Clin Chem Lab Med; 2017 Jul; 55(8):1168-1177. PubMed ID: 28107167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
